诊断学理论与实践 ›› 2022, Vol. 21 ›› Issue (04): 450-455.doi: 10.16150/j.1671-2870.2022.04.006
胡静静1,2, 吕海伟1,2, 荀静娜2, 沈银忠2, 刘莉2(), 卢洪洲1,3()
收稿日期:
2022-04-01
出版日期:
2022-08-25
发布日期:
2022-11-07
通讯作者:
刘莉,卢洪洲
E-mail:liuli@shphc.org.cn;luhongzhou@fudan.edu.cn
基金资助:
HU Jingjing1,2, LÜ Haiwei1,2, XUN Jingna2, SHEN Yinzhong2, LIU Li2(), LU Hongzhou1,3()
Received:
2022-04-01
Online:
2022-08-25
Published:
2022-11-07
Contact:
LIU Li,LU Hongzhou
E-mail:liuli@shphc.org.cn;luhongzhou@fudan.edu.cn
摘要:
目的:分析上海市艾滋病合并分枝杆菌感染患者的菌种分布特征。方法:收集2012年1月1日至2021年12月31日间上海市公共卫生临床中心9 619例门诊及住院艾滋病且有分枝杆菌培养记录的患者,获取培养阳性者的分离菌株,采用结核菌群特异性分泌蛋白MPB64免疫胶体金法或分枝杆菌测序(16S rDNA)法鉴定菌种,分析艾滋病合并分枝杆菌感染患者的菌种分布特征。结果:艾滋病合并分枝杆菌培养阳性患者共1 478例(15.4%),其中有菌种鉴定结果的患者1 367例。结核分枝杆菌复合群(Mycobacterium tuberculosis complex,MTBC)患者为494例(36.1%),非结核分枝杆菌(non-tuberculous mycobacteria,NTM)患者838(61.3%)例,MTBC兼NTM混合感染患者35例(2.6%)。2012年至2021年的分枝杆菌培养阳性病例中,鉴定为NTM(不包含MTBC兼NTM混合感染患者)的构成比逐年分别为55.2%(53/96)、65.5%(78/119)、66.2%(90/136)、55.1%(70/127)、61.6%(93/151)、66.1%(111/168)、58.9%(99/168)、61.8%(94/152)、63.6%(77/121)、56.6%(73/129)。MTBC感染患者、NTM感染患者及MTBC兼NTM混合感染患者的组织标本均以痰液为主,痰液标本构成比为68.0%(336/494)、78.0%(654/838)和88.6%(31/35),其次为血液。1 271例分枝杆菌培养阳性患者为感染与免疫科收治,其中NTM占比为58.5%(743/1 271)。结论:在2012年至2021年间,上海市艾滋病患者合并分枝杆菌培养阳性率为15.4%(1 478/9 619),其中历年NTM构成比高于MTBC,临床医师需高度重视NTM的诊治。
中图分类号:
胡静静, 吕海伟, 荀静娜, 沈银忠, 刘莉, 卢洪洲. 2012年至2021年上海市艾滋病合并分枝杆菌感染患者的菌种分布特征[J]. 诊断学理论与实践, 2022, 21(04): 450-455.
HU Jingjing, LÜ Haiwei, XUN Jingna, SHEN Yinzhong, LIU Li, LU Hongzhou. Characteristcs of mycobacterial species distribution in acquired immunodeficiency syndrome patients with mycobacterial infection in Shanghai[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 450-455.
表1
不同类型标本MTBC与NTM分离情况[n(%)]
标本类型 | MTBC (n=494) | NTM (n=838) | MTBC兼NTM (n=35) |
---|---|---|---|
痰液 | 336(68.0) | 654(78.0) | 31(88.6) |
血液 | 83(16.8) | 160(19.1) | 8(22.9) |
粪便 | 24(4.9) | 59(7.0) | 5(14.3) |
脑脊液 | 33(6.7) | 13(1.6) | 2(5.7) |
穿刺液 | 16(3.2) | 17(2.0) | 0(0) |
灌洗液 | 11(2.2) | 17(2.0) | 1(2.9) |
胸水 | 23(4.7) | 5(0.6) | 1(2.9) |
分泌物 | 14(2.8) | 11(1.3) | 0(0) |
尿液 | 7(1.4) | 11(1.3) | 2(5.7) |
支刷物 | 1(0.2) | 6(0.7) | 0(0) |
腹水 | 3(0.6) | 3(0.4) | 0(0) |
引流物 | 5(1.0) | 0(0) | 0(0) |
[1] | Haworth CS, Banks J, Capstick T, et al. British thoracic society guideline for the management of non-tuberculous mycobacterial pulmonary disease(NTM-PD)[J]. BMJ Open Respir Res, 2017, 4(1):e000242. |
[2] | Bryant JM, Grogono DM, Rodriguez-Rincon D, et al. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium[J]. Scie-nce, 2016, 354(6313):751-757. |
[3] | Agizew T, Basotli J, Alexander H, et al. Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay[J]. PLoS One, 2017, 12(12):e0189981. |
[4] |
Rivero-Lezcano OM, González-Cortés C, Mirsaeidi M. The unexplained increase of nontuberculous mycobacteriosis[J]. Int J Mycobacteriol, 2019, 8(1):1-6.
doi: 10.4103/ijmy.ijmy_18_19 pmid: 30860172 |
[5] |
Koenig SP, Kim A, Shepherd BE, et al. Increased mortality after tuberculosis treatment completion in persons living with human immunodeficiency virus in Latin America[J]. Clin Infect Dis, 2020, 71(1):215-217.
doi: 10.1093/cid/ciz1032 pmid: 31629369 |
[6] | Kobayashi T, Nishijima T, Teruya K, et al. High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era[J]. PLoS One, 2016, 11(3):e0151682. |
[7] |
LIN Q, MO L, SU X, et al. Distribution characteristics of drug susceptibility test results of tuberculosis and non-tuberculous bacilli in patients with opportunistic infections of AIDS[J]. J Tuberc Res, 2021, 9(4):256-265.
doi: 10.4236/jtr.2021.94024 URL |
[8] | 王娟娟, 施旭东, 肖园园, 等. 南京地区HIV/AIDS患者分枝杆菌感染分布及耐药性分析[J]. 临床检验杂志, 2021, 39(2):148-150. |
Wang JJ, Shi XD, Xiao YY, et al. Analysis of mycobacterium infection distribution and drug resistance in HIV/AIDS patients in Nanjing[J]. Chin J Clin Lab Sci, 2021, 39(2):148-150. | |
[9] | 邓西子, 唐小平, 雷杰, 等. 广州地区艾滋病患者合并感染分枝杆菌菌种的分布特征[J]. 中华传染病杂志, 2015(6):331-334. |
Deng XZ, Tang XP, Lei J, et al. The mycobacterial species distribution in acquired immunodeficiency syndrome patients in Guangzhou[J]. Chin J Infect Dis, 2015(6):331-334. | |
[10] | 邓晓军, 张峣, 杨炼, 等. 艾滋病合并非结核分枝杆菌感染的流行病学调查与临床特征分析[J]. 中外医疗, 2013, 32(24):53-54,56. |
Deng XJ, Zhang X, Yang L, et al. Epidemiological investigation and clinical characteristics of AIDS co-infection with non-tuberculous mycobacteria[J]. China Foreign Med Treat, 2013, 32(24):53-54. | |
[11] | 黄文滨, 张满娥, 卢志华, 等. 福建省龙岩市333份分枝杆菌菌种鉴定结果回顾性分析[J]. 检验医学与临床, 2020, 17(22):3275-3278. |
Huang WB, Zhang ME, Lu ZH, et al. Retrospective analysis of the identification results of 333 Mycobacterium species in Longyan City, Fujian Province[J]. Lab Med Clin, 2020, 17(22):3275-3278. | |
[12] | 陈晓. 2009-2013年我院非结核分枝杆菌菌种分布及临床特点[C]. 杭州: 2014年浙江省检验医学学术年会, 2014. |
Chen X. Distribution and clinical characteristics of non-tuberculous mycobacterium species in our hospital from 2009 to 2013: Zhejiang Provincial Academic Conference on Laboratory Medicine[C]. Hangzhou:2014. | |
[13] |
Bjerrum S, Oliver-Commey J, Kenu E, et al. Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana[J]. Trop Med Int Health, 2016, 21(9):1181-1190.
doi: 10.1111/tmi.12749 pmid: 27383726 |
[14] | Agizew T, Basotli J, Alexander H, et al. Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: implications for diagnostic algorithms using Xpert MTB/RIF assay[J]. PLoS One, 2017, 12(12):e0189981. |
[15] |
Chanda-Kapata P, Kapata N, Klinkenberg E, et al. Non-tuberculous mycobacteria (NTM) in Zambia: prevalence, clinical, radiological and microbiological characteristics[J]. BMC Infect Dis, 2015, 15:500.
doi: 10.1186/s12879-015-1264-6 pmid: 26545357 |
[16] |
Karamat A, Ambreen A, Ishtiaq A, et al. Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan[J]. BMC Infect Dis, 2021, 21(1):381.
doi: 10.1186/s12879-021-06086-8 pmid: 33894767 |
[17] |
Bouso JM, Planet PJ. Complete nontuberculous mycobacteria whole genomes using an optimized DNA extraction protocol for long-read sequencing[J]. BMC Genomics, 2019, 20(1):793.
doi: 10.1186/s12864-019-6134-y pmid: 31666009 |
[18] | Deggim-Messmer V, Bloemberg GV, Ritter C, et al. Diagnostic molecular mycobacteriology in regions with low tuberculosis endemicity: combining real-time PCR assays for detection of multiple mycobacterial pathogens with line probe assays for identification of resistance mutations[J]. E Bio Medicine, 2016, 9:228-237. |
[19] |
Genc GE, Demir M, Yaman G, et al. Evaluation of MALDI-TOF MS for identification of nontuberculous mycobacteria isolated from clinical specimens in mycobacteria growth indicator tube medium[J]. New Microbiol, 2018, 41(3):214-219.
pmid: 29874386 |
[20] |
Akyar I, Çavuolu C, Aya M, et al. Evaluation of the performance of MALDI-TOF MS and DNA sequence analysis in the identification of mycobacteria species[J]. Turk J Med Sci, 2018, 48(6):1351-1357.
doi: 10.3906/sag-1801-198 pmid: 30543090 |
[21] |
Huang WC, Yu MC, Huang YW. Identification and drug susceptibility testing for nontuberculous mycobacteria[J]. J Formos Med Assoc, 2020, 119(Suppl 1):S32-S41.
doi: 10.1016/j.jfma.2020.05.002 URL |
[22] |
Mirzapour A, Alam AN, Bostanabadi SZ, et al. Identification of nontuberculous mycobacteria by high-performance liquid chromatography from patients in tehran[J]. Int J Mycobacteriol, 2016, 5(Suppl 1):S214.
doi: 10.1016/j.ijmyco.2016.09.003 URL |
[23] |
Baliga S, Murphy C, Sharon L, et al. Rapid method for detecting and differentiating Mycobacterium tuberculosis complex and non-tuberculous mycobacteria in sputum by fluorescence in situ hybridization with DNA probes[J]. Int J Infect Dis, 2018, 75:1-7.
doi: S1201-9712(18)34469-2 pmid: 30048818 |
[24] |
Matsumoto Y, Kinjo T, Motooka D, et al. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles[J]. Emerg Microbes Infect, 2019, 8(1):1043-1053.
doi: 10.1080/22221751.2019.1637702 URL |
[25] |
Sharma S, Latawa R, Wanchu A, et al. Differential diagnosis of disseminated mycobacterium avium and Mycobacterium tuberculosis infection in HIV patients using duplex PCR[J]. Future Microbiol, 2021, 16(3):159-173.
doi: 10.2217/fmb-2020-0133 URL |
[1] | 沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436. |
[2] | 程齐俭, 陈聆, 杜威, 柳亚慧, 杨华, 肖和平, 时国朝. 首次复治肺结核病结核分枝杆菌对利福平耐药性与rpoB基因RRDR突变的研究[J]. 诊断学理论与实践, 2018, 17(06): 635-639. |
[3] | 何梅芳, 刘健红, 陈春华, 申红玉. 全血γ-干扰素释放试验与ELISA检测结核分枝杆菌抗体在痰菌阴性肺结核辅助诊断中的比较应用[J]. 诊断学理论与实践, 2018, 17(05): 586-589. |
[4] | 张桂红, 夏前林, 单孟林, 郑江花. TSPOT.TB在HIV感染/AIDS合并分枝杆菌感染患者中的诊断价值[J]. 诊断学理论与实践, 2017, 16(04): 404-408. |
[5] | 孙勤, 肖和平,. 结核分枝杆菌耐药性分子检测方法的新进展[J]. 诊断学理论与实践, 2015, 14(05): 464-467. |
[6] | 潘卫,. 结核血清学诊断的现状与挑战[J]. 诊断学理论与实践, 2015, 14(01): 6-9. |
[7] | 陈军, 卢洪洲,. 结核分枝杆菌核酸检测的临床应用[J]. 诊断学理论与实践, 2015, 14(01): 10-12. |
[8] | 刘莉, 卢洪洲,. 非结核分枝杆菌肺病诊断及治疗进展[J]. 诊断学理论与实践, 2015, 14(01): 22-26. |
[9] | 何亦凡, 李惠萍,. 结节病和菌阴性结核病鉴别诊断新方法的临床评价[J]. 诊断学理论与实践, 2013, 12(02): 163-165. |
[10] | 范齐文, 郭建, 钱雪琴, 邓桂林, 吴文娟,. 显微镜观察药物敏感性试验检测结核分枝杆菌对吡嗪酰胺的敏感性[J]. 诊断学理论与实践, 2013, 12(01): 70-74. |
[11] | 古丽仙·吐尔逊, 顾志冬, 陈长强, 周敏, 卫蓓文, 张海晨, 费凤英, 樊绮诗,. 免疫磁性微球富集检测结核分枝杆菌方法的建立[J]. 诊断学理论与实践, 2012, 11(05): 476-480. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||